Olympia Pharmacy 4600 LB McLeod Road Orlando, FL 3281 (800)-991-9079 [email protected] Unfortunately, we cannot issue refunds or accept returns of prescription products for reuse or resale, and all sales are final
When the Breakthrough Obesity G-Agonist Drugs Exceed Expectations The expanding GLP-1 family of drugs and their expanded potential use cases Back last December I wrote about the The New Obesity Breakthrough Drugs, and specifically the striking results in randomized trials for semaglutide (Wegovy) and tirzepatide (Mounjaro) for weight loss, their putative mechanism(s), while also emphasizing their very high cost, lack of plan for successful weaning, and exacerbation of health inequities
However, always disclose all medications to your healthcare provider before starting
Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons
While this is a necessary first step, it frequently creates highly reactive, electrophilic intermediate metabolites that are actually more toxic and dangerous than the original parent compound